Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 12/22/22 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 12/22/22 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 12/22/22 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 12/22/22 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 12/22/22 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 12/22/22 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 12/22/22 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 12/22/22 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 12/22/22 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 12/15/22 | 8-K | Current report filing |
|
   |
5 |
